Arca
Skip to content

Physiological sexual dysfunction

Drug research and approvals for physiological sexual dysfunction: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 107 studies of physiological sexual dysfunction are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 107
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 107 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

4 in phase 3, 10 in phase 2, 4 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition
Bremelanotide
Phase 3 Melanocortin receptor 4 agonist
Prasterone
Phase 3 Unknown
Dapoxetine
Phase 3 Serotonin transporter inhibitor
Tibolone
Phase 3
Sildenafil
Phase 2 Phosphodiesterase 5A inhibitor
Testosterone undecanoate
Phase 2 Androgen Receptor agonist
Alprostadil
Phase 2 Prostanoid EP1 receptor agonist
Oxytocin
Phase 2 Oxytocin receptor agonist
Ginkgo
Phase 2
Tadalafil
Phase 2 Phosphodiesterase 5A inhibitor
Buspirone
Phase 2 Serotonin 1a (5-HT1a) receptor partial agonist
Fispemifene
Phase 2 Estrogen receptor modulator
PF-00446687
Phase 2 Melanocortin receptor 4 agonist
CP-866087
Phase 2 Mu opioid receptor antagonist
Bupropion
Phase 1 Dopamine transporter inhibitor
Caffeine
Phase 1 Adenosine receptor antagonist
Testosterone cypionate
Phase 1 Androgen Receptor agonist
Kaempferol
Phase 1

How Its Trials Ended

44 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 5 whose ending is known, 40% met their primary endpoint, 0% missed it and 60% stopped early.

  • Completed, result not reported2557%
  • Ongoing920%
  • Status unknown511%
  • Met its primary endpoint25%
  • Stopped: enrollment or feasibility25%
  • Stopped: sponsor or business decision12%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.